RxDoctor Payments Data

D Jeffrey Newport

Psychiatry · Miami, FLNPI 1275646291

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $4,185 of the $4,185 with a category attached, or 100.0%. Merck accounts for 88.9% of it on its own, with 1 other manufacturer making up the rest.

$4,185in general payments, 2019–2025

Across 2 payments — averaging $2092.50 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Merck$4K
  • Sage Therapeutics, LLC$465
$536,288in research payments, 2019–2025

Across 10 payments — averaging $53,629 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Sage Therapeutics, LLC$506K
  • Janssen Research & Development, LLC$16K
  • Supernus Pharmaceuticals, Inc.$14K

What the payments were for

  • Consulting fees$4,185100%

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Merck1$3,720
Sage Therapeutics, LLC1$465

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$4,185 in reported general payments places this provider in the 80th percentile of 2,059 psychiatry providers in Florida.

See all psychiatry providers in Florida →

Most prescribed under Part D

DrugClaimsCost to plans & patients
Lithium Carbonate12$144
Clonazepam12$137

Paid to pharmacies, not to this prescriber.

Other psychiatry in Miami

See the full list for Florida →

Where these figures come from

Is this you, or does something look wrong? →